Ionis Pharmaceuticals Inc
(NAS:IONS)
$
35.91
-0.42 (-1.16%)
Market Cap: 5.74 Bil
Enterprise Value: 4.73 Bil
PE Ratio: 0
PB Ratio: 8.65
GF Score: 40/100 Ionis Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 16, 2023 / 02:00PM GMT
Release Date Price:
$35.99
(-0.69%)
Luca Issi
RBC Capital Markets, Research Division - Research Analyst
Luca Issi, senior biotech analyst here at RBC Capital Markets. And today is a great privilege to have Ionis with a fireside chat. Representing the company, we have Brett Monia, Chief Executive Officer.
Brett, thanks so much for joining us. How are you doing today?
Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director
I'm doing great. Thanks, Luca. It's really, really great to be here, and thanks for the opportunity.
Questions & Answers
Luca Issi
RBC Capital Markets, Research Division - Research Analyst
Fantastic. We have a long list of questions here, but maybe before I ask you about the individual programs, can you just talk big picture about what progress has the organization made over the last few months? And maybe most importantly, what's ahead here for Ionis?
Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director
Sure. Happy to. So I think
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot